Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Bioorg Med Chem. 2019 Mar 19;27(9):1845–1854. doi: 10.1016/j.bmc.2019.03.034

Figure 6. Reduction of MRSA USA300 in infected lesions of mice.

Figure 6

Average percent reduction of MRSA CFU/mL in murine skin lesions after treatment with 19 or fusidic acid. A one-way ANOVA with post-hoc Dunnet’s multiple comparisons found no statistical difference between mice treated with fusidic acid and mice treated with compound 19.